More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the "fen" in the fen-phen diet drug combination.
American Home Products has agreed to pay 3.75 billion to settle thousands of lawsuits filed nationwide by people claiming health problems due to the company's once popular fen-phen diet drug combination, the company announced today.
The lawsuit asserts that American Home Products Corp. underreported the instances of pulmonary hypertension as a result of using fenfluramine, the "fen" part of the drug combination.
The Madison, N.J.-based drug maker pulled fenfluramine and Redux off the market in 1997 at the Food and Drug Administration's request after a Mayo Clinic study linked the drugs to potentially fatal heart valve damage.
More than 2,600 individual lawsuits have been filed against fen-phen, and class-action lawsuits asking the company to pay for medical checkups and future medical treatments have been certified in several states.
The suit comes only four weeks after a Jefferson County jury awarded about 400 million to plaintiffs who made similar claims against American Home Attorney Wilbur O. Colom of Columbus said the latest lawsuit seeks a larger award, which he said should send diet pill manufacturers a strong message.
In a major step toward resolving health claims against the diet drug combination fen-phen, drug maker American Home Products said just 1 percent of the drug's users have opted out of a multibillion dollar settlement.
More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the "fen"
